103 related articles for article (PubMed ID: 14757281)
1. Expression of p53, bcl-2 and growth hormone receptor in atrophic type of actinic keratosis.
Stanimirović A; Cupić H; Bosnjak B; Tomas D; Balicević D; Kruslin B; Belicza M
J Dermatol Sci; 2004 Feb; 34(1):49-53. PubMed ID: 14757281
[No Abstract] [Full Text] [Related]
2. Expression of p53, bcl-2 and growth hormone receptor in actinic keratosis, hypertrophic type.
Stanimirović A; Cupić H; Bosnjak B; Kruslin B; Belicza M
Arch Dermatol Res; 2003 Jul; 295(3):102-8. PubMed ID: 12756585
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infection in actinic keratosis and bowen's disease: comparative study with expression of cell-cycle regulatory proteins p21(Waf1/Cip1), p53, PCNA, Ki-67, and Bcl-2 in positive and negative lesions.
Mitsuishi T; Kawana S; Kato T; Kawashima M
Hum Pathol; 2003 Sep; 34(9):886-92. PubMed ID: 14562284
[TBL] [Abstract][Full Text] [Related]
4. Expression of Bcl-2 protein in human laryngeal keratoses.
Fouret PJ; Rodenas A; Dabit D; Saint-Guily JL; Callard P
Pathobiology; 1995; 63(4):192-6. PubMed ID: 8866790
[TBL] [Abstract][Full Text] [Related]
5. Comparison of benign keratoses using p53, bcl-1, and bcl-2.
Ko CJ; Shintaku P; Binder SW
J Cutan Pathol; 2005 May; 32(5):356-9. PubMed ID: 15811121
[TBL] [Abstract][Full Text] [Related]
6. Analysis of apoptosis-associated molecules Erythroid differentiation regulator 1, bcl-2 and p53 in actinic keratosis after treatment with ingenol mebutate.
Woo YR; Lim JH; Jeong SW; Cho DH; Park HJ
Exp Dermatol; 2017 Nov; 26(11):1012-1017. PubMed ID: 28370377
[TBL] [Abstract][Full Text] [Related]
7. Correlation between Bcl-2 and Bax in atrophic and hypertrophic type of actinic keratosis.
Tomas D; Kruslin B; Cupic H; Stanimirovic A; Bosnjak B; Lovricevic I; Belicza M
J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):51-7. PubMed ID: 16405608
[TBL] [Abstract][Full Text] [Related]
8. Pagetoid variant of actinic keratosis with or without squamous cell carcinoma of sun-exposed skin: a lesion simulating extramammary Paget's disease.
Mai KT; Alhalouly T; Landry D; Stinson WA; Perkins DG; Yazdi HM
Histopathology; 2002 Oct; 41(4):331-6. PubMed ID: 12383215
[TBL] [Abstract][Full Text] [Related]
9. P27 and mib1 expression in actinic keratosis, Bowen disease, and squamous cell carcinoma.
Oh CW; Penneys N
Am J Dermatopathol; 2004 Feb; 26(1):22-6. PubMed ID: 14726819
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of proliferation- and apoptosis-related markers in lentigo maligna and solar keratosis keratinocytes.
Feinmesser M; Tsabari C; Fichman S; Hodak E; Sulkes J; Okon E
Am J Dermatopathol; 2003 Aug; 25(4):300-7. PubMed ID: 12876487
[TBL] [Abstract][Full Text] [Related]
11. The characteristics of human papillomavirus expression and cell proliferation in actinic keratosis and Bowen's disease of the skin.
Kvlividze O; Gogiashvili L; Burkadze G
Georgian Med News; 2006 Jul; (136):108-12. PubMed ID: 16905862
[TBL] [Abstract][Full Text] [Related]
12. Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pretumorigenic, and tumorigenic keratinocytic hyperproliferative lesions.
Hussein MR; Al-Badaiwy ZH; Guirguis MN
J Cutan Pathol; 2004 Nov; 31(10):643-51. PubMed ID: 15491323
[TBL] [Abstract][Full Text] [Related]
13. Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer.
Einspahr JG; Nelson MA; Saboda K; Warneke J; Bowden GT; Alberts DS
Clin Cancer Res; 2002 Jan; 8(1):149-55. PubMed ID: 11801552
[TBL] [Abstract][Full Text] [Related]
14. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
15. The development of actinic keratosis into invasive squamous cell carcinoma: evidence and evolving classification schemes.
Anwar J; Wrone DA; Kimyai-Asadi A; Alam M
Clin Dermatol; 2004; 22(3):189-96. PubMed ID: 15262304
[TBL] [Abstract][Full Text] [Related]
16. Disseminated superficial actinic porokeratosis: a report of eight cases.
Donald GF; Hunter GA
Australas J Dermatol; 1968 Dec; 9(4):335-44. PubMed ID: 5708573
[No Abstract] [Full Text] [Related]
17. Epidermal growth factor receptor (EGFR) abundance correlates with p53 and Bcl-2 accumulation and patient age in a small cohort of North African nasopharyngeal carcinoma patients.
Bourouba M; Benyelles-Boufennara A; Terki N; Baraka-Kerboua E; Bouzid K; Touil-Boukoffa C
Eur Cytokine Netw; 2011 Mar; 22(1):38-44. PubMed ID: 21388911
[TBL] [Abstract][Full Text] [Related]
18. [What is your diagnosis? Pigmented, actinic (solar) keratosis].
Böni R
Praxis (Bern 1994); 2003 Oct; 92(43):1809-10. PubMed ID: 14619211
[No Abstract] [Full Text] [Related]
19. Actinic keratosis. Early skin cancer?
Mayo Clin Health Lett; 2004 Nov; 22(11):6. PubMed ID: 15619753
[No Abstract] [Full Text] [Related]
20. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
